Metabolic dysfunction-associated steatohepatitis (MASH) is often referred to as a “silent disease,” as it typically shows no signs of symptoms in early stages. But it can come with certain ...

Although this version of liver disease, MASH, is not primarily attributed to alcohol, drinking — especially more than 21 alcoholic drinks per week for men or 14 for women — can increase your risk.

Last week's survey by the British Potato Council revealed that we prefer mash to chips ... One portion provides a woman's healthy limit for saturates for the day. In the Naked Chef, Jamie suggests ...

MASH, which was previously known as non–alcohol related steatohepatitis (NASH), is often asymptomatic or leads to nonspecific symptoms, making progression to more severe stages of liver disease ...

At 10.30am on a chilly Saturday the queue outside Manze’s pie-and-mash shop on Deptford High Street stretches 50 metres down the street. The restaurant has been a fixture of the south-east ...

Opens in a new tab or window In patients with severe metabolic dysfunction-associated steatohepatitis (MASH), the investigational drug efruxifermin significantly improved fibrosis without ...

Potential competition from GLP-1 drugs and other MASH therapies exists, but REZDIFFRA's combination use and first-mover advantage mitigate these risks. Analysts project $515M in 2025 sales ...

The Revd Canon Dr Rachel Mash, Environmental Coordinator of the Anglican Church of Southern Africa, has been appointed as a member of the United Nations Environment Programme (UNEP) Faith for Earth ...

Women leaders bring unique strengths to the C-suite, including enhanced creativity, empathy, and ... [+] collaborative skills. As we navigate an era defined by rapid transformation, the increasing ...

Three years after its announcement, the future of Warner Bros.'s Wonder Woman game is reportedly in question - with its release said to still be "years away" if it ever launches at all.

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...